| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $482.0M | +11.3% |
| Cost of Revenue | $115.7M | +8.7% |
| Gross Profit | $366.3M | +12.1% |
| R&D Expense | $50.3M | +13.3% |
| SG&A Expense | $294.5M | +9.2% |
| Operating Income | -$1.3M | -110.2% |
| Pre-tax Income | -$2.8M | -127.0% |
| Income Tax | -$3.7M | -167.3% |
| Net Income | $861K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.6M | +30.6% |
| Accounts Receivable | $109.9M | +34.0% |
| Inventory | $26.2M | -7.2% |
| Current Assets | $285.9M | +27.1% |
| Total Assets | $497.9M | +8.2% |
| Current Liabilities | $77.5M | -3.8% |
| Total Liabilities | $112.6M | -37.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.2M | -54.0% |
| Capital Expenditures | $10.0M | -58.8% |
| Investing Cash Flow | -$10.0M | +58.8% |
| Financing Cash Flow | $27.6M | +602.0% |
| Free Cash Flow | $4.2M | -36.3% |
| -82.6% |
| EPS (Basic) | -$0.01 | -125.0% |
| EPS (Diluted) | -$0.01 | -125.0% |
| Stockholders' Equity |
| $262.9M |
| -5.7% |